Sandra Jensen

3PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 12, 2025
ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?

Sandra Jensen, Tove Tvedskov, Troels Bechmann

|Sep 02, 2025
ASO Visual Abstract: Additional Axillary Disease After Neoadjuvant Chemotherapy in patients with Clinically Node-Negative but Sentinel Node-Positive disease.

S Jensen, T F Tvedskov, T Bechmann

|Aug 21, 2025
Additional Axillary Disease After Neoadjuvant Chemotherapy for Patients with Clinically Node-Negative but Sentinel Node-Positive Disease.

S Jensen, T F Tvedskov, T Bechmann

Pageof 1

Frequent Collaborators